Recalcitrant, delayed pressure urticaria treated with long-term intravenous immunoglobulin
Saved in:
Main Authors: | Yssra S. Soliman, MD (Author), Henry W. Lim, MD (Author), Holly A. Kerr, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to low-dose intravenous immunoglobulin in a case of recalcitrant Darier disease
by: Adeline Legrand, MD, et al.
Published: (2020) -
Successful treatment of recalcitrant juvenile pemphigus foliaceus with intravenous immunoglobulin and rituximab
by: Hock Gin Teo, et al.
Published: (2022) -
Recalcitrant urticaria controlled with a combination of mycophenolate mofetil and sulfasalazine
by: Alyssa G. Ashbaugh, MD, et al.
Published: (2021) -
Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses
by: Roberta Scarpone, et al.
Published: (2020) -
Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab
by: Katelyn Singh, MD, et al.
Published: (2024)